Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? | SpringerLink
HER2 activation. A, receptor dimerization is required for HER2 function... | Download Scientific Diagram
The role of HER2 in cancer therapy and targeted drug delivery - ScienceDirect
Herceptin
Anti-HER2 therapies
Chromosome 17 loci of HER2 and other genes associated with... | Download Scientific Diagram
HER2 Testing in Breast Cancer
HER2 Amplification or Overexpression in Upper GI Tract and Breast Cancer with Clinical Diagnosis and Treatment | IntechOpen
HER2 Biomarker | Colorectal Cancer Alliance
HER2 and Herceptin
Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
IJMS | Free Full-Text | Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
How Herceptin® (trastuzumab) is Thought to Work | Herceptin® (trastuzumab) for HER2+ Metastatic Breast Cancer
HER2 signaling pathway. HER2 as well as the other members of the EGFR... | Download Scientific Diagram
HER2| Breast Cancer |Gastric Cancer | Lung Cancer | OriGene
Raji-HER2 cells | ADCC target cells | InvivoGen
Cancers | Free Full-Text | Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
Narratives on Collaboration
Evolving novel anti-HER2 strategies - The Lancet Oncology
What is HER2+ Metastatic Breast Cancer? | KADCYLA® (ado-trastuzumab emtansine)
HER2 - Wikipedia
HER2-Driven Carcinogenesis: New Mouse Models for Novel Immunotherapies | IntechOpen
Tucatinib Approved for HER2-Positive Colorectal Cancer - NCI
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now | npj Breast Cancer
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer | npj Breast Cancer
HER2 Biomarker in Colon Cancer | Know Your Biomarker
AstraZeneca on X: "Approx. 20-30% of #breastcancer have a faulty HER2 gene which makes too many copies of itself – this is known as gene amplification. This results in more HER2 receptors